✦ LIBER ✦

Comparative pharmacokinetics and bioavailability of four alkaloids in different formulations from Corydalis decumbens

✍ Scribed by Wu, Chunzhen; Yan, Renjie; Zhang, Rongjin; Bai, Fan; Yang, Yifang; Wu, Zhaoyang; Wu, Anming

Book ID: 120469024
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 742 KB
Volume: 149
Category: Article
ISSN: 0378-8741
DOI: 10.1016/j.jep.2013.05.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative bioavailability of different

Comparative bioavailability of different formulations of levothyroxine and liothyronine in healthy volunteers

✍ Leggio, G. M.; Incognito, T.; Privitera, G.; Marano, M. R.; Drago, F. 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 130 KB

Enantioselective pharmacokinetics and bi

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

✍ R. Hermann; G. Niebch; H.O. Borbe; H. Fieger-Büschges; P. Ruus; H. Nowak; H. Rie 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 599 KB

Pharmacokinetics and bioavailability of

Pharmacokinetics and bioavailability of pentoxifylline in healthy volunteers-a comparative study of three oral formulations

✍ Milena Pokrajac; Branislava Miljković; Dragan Simić; Branka Brzaković; Aleksandr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 355 KB

Relative bioavailability and comparative

Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs

✍ Gonzalo Suárez, Luis Alvarez, Daniel Castells, Oscar Correa… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 233 KB

Pharmacokinetics and Comparative Bioavai

Pharmacokinetics and Comparative Bioavailability of Two Metformin Formulations after Single-Dose Administration in Healthy Subjects

✍ Ivanka Atanasova, Kristina Bozhinova, Denitza Todorova, Dr Dimiter Terziivanov 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 137 KB

Comparative in vitro and in vivo bioavai

Comparative in vitro and in vivo bioavailability of naproxen from tablet and caplet formulations

✍ B. G. Charles; G. A. G. Mogg 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

## Abstract A 500 mg dose of naproxen in a caplet formulation (product A) or a tablet (Naprosyn 500, product B) was administered to 14 fasting healthy subjects on two separate occasions, separated by a 1–2 week washout period in an open, randomized crossover. Blood samples were drawn periodically a